Analysts have been eager to weigh in on the Healthcare sector with new ratings on Sanofi (SNYNF – Research Report), Roche Holding AG (RHHVF – ...

Summit Therapeutics' shares dropped 36% after ivonescimab data showed no significant survival benefit. Click to read if SMMT ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on BioNTech SE (BNTX – Research Report) and Opko Health (OPK – Research Report).

Rocketing to a price of $106.75 during today's morning trading session, shares of BioNTech SE are still -23.88% below their ...

"We are currently exploring various possibilities, including partial investment," the automaker said in a filing with the Tokyo stock exchange ... and BioNTech (NASDAQ: BNTX) were down ...

The President Donald Trump administration's request for Novavax Inc. to conduct new clinical trials for its COVID-19 vaccine ...

Summit Therapeutics highlights China approval of Akeso's ivonescimab for NSCLC, with enrollment ongoing for Phase 3 HARMONi-7 ...

Pfizer (PFE) stock slips after the company's lower than expected Q1 2025 revenue and the firm seeks acquisitions to boost its ...

Detailed price information for Summit Therapeu ADR (SMMT-Q) from The Globe and Mail including charting and trades.

Disney’s stock price has significantly risen since its IPO. (read more) Disney stock has been a part of six stock splits since the IPO,The first post IPO stock split happened in 1967 which was a ...